Cargando…
Impairment of insulin signalling in peripheral tissue fails to extend murine lifespan
Impaired insulin/IGF1 signalling has been shown to extend lifespan in model organisms ranging from yeast to mammals. Here we sought to determine the effect of targeted disruption of the insulin receptor (IR) in non‐neuronal tissues of adult mice on the lifespan. We induced hemizygous (PerIRKO (+/−))...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5506415/ https://www.ncbi.nlm.nih.gov/pubmed/28544360 http://dx.doi.org/10.1111/acel.12610 |
_version_ | 1783249558106537984 |
---|---|
author | Merry, Troy L. Kuhlow, Doreen Laube, Beate Pöhlmann, Doris Pfeiffer, Andreas F. H. Kahn, C. Ronald Ristow, Michael Zarse, Kim |
author_facet | Merry, Troy L. Kuhlow, Doreen Laube, Beate Pöhlmann, Doris Pfeiffer, Andreas F. H. Kahn, C. Ronald Ristow, Michael Zarse, Kim |
author_sort | Merry, Troy L. |
collection | PubMed |
description | Impaired insulin/IGF1 signalling has been shown to extend lifespan in model organisms ranging from yeast to mammals. Here we sought to determine the effect of targeted disruption of the insulin receptor (IR) in non‐neuronal tissues of adult mice on the lifespan. We induced hemizygous (PerIRKO (+/−)) or homozygous (PerIRKO (−/−)) disruption of the IR in peripheral tissue of 15‐weeks‐old mice using a tamoxifen‐inducible Cre transgenic mouse with only peripheral tissue expression, and subsequently monitored glucose metabolism, insulin signalling and spontaneous death rates over 4 years. Complete peripheral IR disruption resulted in a diabetic phenotype with increased blood glucose and plasma insulin levels in young mice. Although blood glucose levels returned to normal, and fat mass was reduced in aged PerIRKO (−/−) mice, their lifespan was reduced. By contrast, heterozygous disruption had no effect on lifespan. This was despite young male PerIRKO (+/−) mice showing reduced fat mass and mild increase in hepatic insulin sensitivity. In conflict with findings in metazoans like Caenorhabditis elegans and Drosophila melanogaster, our results suggest that heterozygous impairment of the insulin signalling limited to peripheral tissues of adult mice fails to extend lifespan despite increased systemic insulin sensitivity, while homozygous impairment shortens lifespan. |
format | Online Article Text |
id | pubmed-5506415 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-55064152017-08-01 Impairment of insulin signalling in peripheral tissue fails to extend murine lifespan Merry, Troy L. Kuhlow, Doreen Laube, Beate Pöhlmann, Doris Pfeiffer, Andreas F. H. Kahn, C. Ronald Ristow, Michael Zarse, Kim Aging Cell Original Articles Impaired insulin/IGF1 signalling has been shown to extend lifespan in model organisms ranging from yeast to mammals. Here we sought to determine the effect of targeted disruption of the insulin receptor (IR) in non‐neuronal tissues of adult mice on the lifespan. We induced hemizygous (PerIRKO (+/−)) or homozygous (PerIRKO (−/−)) disruption of the IR in peripheral tissue of 15‐weeks‐old mice using a tamoxifen‐inducible Cre transgenic mouse with only peripheral tissue expression, and subsequently monitored glucose metabolism, insulin signalling and spontaneous death rates over 4 years. Complete peripheral IR disruption resulted in a diabetic phenotype with increased blood glucose and plasma insulin levels in young mice. Although blood glucose levels returned to normal, and fat mass was reduced in aged PerIRKO (−/−) mice, their lifespan was reduced. By contrast, heterozygous disruption had no effect on lifespan. This was despite young male PerIRKO (+/−) mice showing reduced fat mass and mild increase in hepatic insulin sensitivity. In conflict with findings in metazoans like Caenorhabditis elegans and Drosophila melanogaster, our results suggest that heterozygous impairment of the insulin signalling limited to peripheral tissues of adult mice fails to extend lifespan despite increased systemic insulin sensitivity, while homozygous impairment shortens lifespan. John Wiley and Sons Inc. 2017-05-22 2017-08 /pmc/articles/PMC5506415/ /pubmed/28544360 http://dx.doi.org/10.1111/acel.12610 Text en © 2017 The Authors. Aging Cell published by the Anatomical Society and John Wiley & Sons Ltd. This is an open access article under the terms of the Creative Commons Attribution (http://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Articles Merry, Troy L. Kuhlow, Doreen Laube, Beate Pöhlmann, Doris Pfeiffer, Andreas F. H. Kahn, C. Ronald Ristow, Michael Zarse, Kim Impairment of insulin signalling in peripheral tissue fails to extend murine lifespan |
title | Impairment of insulin signalling in peripheral tissue fails to extend murine lifespan |
title_full | Impairment of insulin signalling in peripheral tissue fails to extend murine lifespan |
title_fullStr | Impairment of insulin signalling in peripheral tissue fails to extend murine lifespan |
title_full_unstemmed | Impairment of insulin signalling in peripheral tissue fails to extend murine lifespan |
title_short | Impairment of insulin signalling in peripheral tissue fails to extend murine lifespan |
title_sort | impairment of insulin signalling in peripheral tissue fails to extend murine lifespan |
topic | Original Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5506415/ https://www.ncbi.nlm.nih.gov/pubmed/28544360 http://dx.doi.org/10.1111/acel.12610 |
work_keys_str_mv | AT merrytroyl impairmentofinsulinsignallinginperipheraltissuefailstoextendmurinelifespan AT kuhlowdoreen impairmentofinsulinsignallinginperipheraltissuefailstoextendmurinelifespan AT laubebeate impairmentofinsulinsignallinginperipheraltissuefailstoextendmurinelifespan AT pohlmanndoris impairmentofinsulinsignallinginperipheraltissuefailstoextendmurinelifespan AT pfeifferandreasfh impairmentofinsulinsignallinginperipheraltissuefailstoextendmurinelifespan AT kahncronald impairmentofinsulinsignallinginperipheraltissuefailstoextendmurinelifespan AT ristowmichael impairmentofinsulinsignallinginperipheraltissuefailstoextendmurinelifespan AT zarsekim impairmentofinsulinsignallinginperipheraltissuefailstoextendmurinelifespan |